Ingrid Lea Scully
8Patents
3h-index
25Co-inventors
49Inventor score
Filing activity: Jun 22, 2010 → Jan 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10226525B2 | Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US8568735B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 10 | Active |
| US8889145B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 5 | Active |
| US10946086B2 | Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9114105B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 3 | Active |
| US9125951B2 | Compositions and methods for preparing Staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions | Human Necessities | 2 | Active |
| US9127050B2 | Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease | Human Necessities | 1 | Active |
| US9623100B2 | Compositions and methods for preparing Staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.